N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine

N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine Suppliers list
Company Name: Nanjing Baifuli Technology Co., Ltd.  
Tel: 25-25-58740604 15951658055
Email: sales@unisyn.cn
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com
Company Name: Cool Pharm, Ltd  
Tel: 021-60455363 18019463053
Email: sales@coolpharm.com
Company Name: Wuhu Nuowei Chemical Technology Co., Ltd  
Tel: 0553-8233716 18055326116
Email: sales@nuowei-chem.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com

N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine manufacturers

N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine Basic information
Product Name:N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine
Synonyms:N6-benzoyl-5'-O-DMT-3'-O-TBDMS-adenosine;N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine;5'-DMT-3'-TBDMS-Bz-rA;Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethyl ethyl)dimethylsilyl]-;5'-DMT-4'-TBDMS-Bz-rA;N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-[(1,1-dimethylethyl)dimethylsilyl]adenosine;N6-benzoyl-5'-O-DMT-3'-O-TBDM;5'-O-DMT-3'-O-TBDMS-Bz-rA
CAS:81256-88-4
MF:C44H49N5O7Si
MW:787.98
EINECS:
Product Categories:
Mol File:81256-88-4.mol
N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine Structure
N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine Chemical Properties
density 1.232±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
storage temp. 2-8°C
solubility DMSO : 100 mg/mL (126.91 mM)
pka7.871±0.43(predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine Usage And Synthesis
Uses5'-DMT-3'-TBDMS-Bz-rA is a nucleoside with protective and modification effects.
Synthesis
Benzamide, N-[9-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-α-D-ribofuranosyl]-9H-purin-6-yl]-

129666-75-7

tert-Butyldimethylsilyl chloride

18162-48-6

N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine

81256-88-4

Benzamide, N-[9-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-α-D-ribofuranosyl]-9H-purin-6-yl]-

129681-71-6

Synthesis of N-(9-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-3-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide ( CAS:129681-71-6) was prepared in the following general procedure: to a mixed solution of tetrahydrofuran (THF, 800 mL) and pyridine (15 mL) of the product of the previous step (200 g, 296.9 mmol) was added, in sequence, silver cyanide (AgNCb, 83.2 g, 489.8 mmol, 1.65 eq.) and tert-butyldimethylchlorosilane ( TBSCl, 78.7 g, 522.5 mmol, 1.76 equiv). The reaction mixture was stirred at room temperature for 16 hours. After completion of the reaction, the mixture was filtered, diluted with water (H2O, 1.0 L) and extracted with ethyl acetate (EtOAc, 3 x 1.0 L). The organic layers were combined, washed with brine (2 × 1.0 L), dried over anhydrous sodium sulfate (Na2SO4) and concentrated under reduced pressure. The residue was purified by silica gel (SiO2) column chromatography with petroleum ether/ethyl acetate (3:1 to 1:1) as eluent to give the products D-2a (114 g, 145 mmol, 49% yield) and D-2b (53 g, 68 mmol, 23% yield).

References[1] Patent: WO2018/156625, 2018, A1. Location in patent: Paragraph 0296
[2] Canadian Journal of Chemistry, 1982, vol. 60, p. 111 - 120
N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine Preparation Products And Raw materials
Raw materialsBenzamide, N-[9-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-α-D-ribofuranosyl]-9H-purin-6-yl]--->tert-Butyldimethylsilyl chloride-->Silver nitrate-->Tetrahydrofuran-->Pyridine
Tag:N6-benzoyl-3'-O-t-butyldiMethylsilyl-5'-O-(4,4'-diMethoxytrityl)-adenosine(81256-88-4) Related Product Information
o-Phenetidine Ceteareth-5 Sodium levothyroxine 2,2-Diphenylacetic acid 5'-O-DMTr-N2-isobutyrylguanosine 5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine 5'-DMT-RIBO ADENOSINE (N-BZ) N2-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-3'-O-tert-butyldimethylsilyl guanosine 5'-O-DMT-2'-O-iBu-N-Bz-Guanosine